| StemCells announced that it has closed the sale of 10M shares of common stock and warrants to purchase four million shares of common stock, for gross proceeds of $12.5M. The common stock and warrants were sold in units at a price of $1.25 per unit, with each unit consisting of one share of common stock and a warrant to purchase 0.40 share of common stock at an exercise price of $1.50 per share. The proceeds will be used for general corporate purposes, including working capital, product development and capital expenditures, as well as for other strategic purposes. . :theflyonthewall.com |
